Universita di Verona University
Recent work: Efficacy and safety of Nintedanib esilate soft capsules in the treatment of pulmonary fibrosis in healed moderate to severe patients of novel coronavirus pneumonia (COVID-19): a single-center, randomized, placebo-controlled trial
Technology:
COVID Labs/Universities
Industry:
COVID R&D
Headquarters:
Italy
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership